The certification covers Bend’s manufacture of clinical pharmaceutical supplies for human consumption and testing of the supplies at the company’s GMP facilities.
Bend Research CEO Rod Ray said, "The strategic addition of this certification — combined with new capabilities such as high-potency spray-drying and future commercial spray-drying — strengthens Bend Research’s position as a preferred provider for oral solubilized, modified-release, inhalation, and many other dosage forms."
All health authorities in the EU in addition to authorities of other countries that recognize EU certification recognizes the MPA GMP certificate.